| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/24/2002 | US6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents |
| 09/24/2002 | US6455243 Detecting malnutrition in mammals by measuring activity of mitochondrial enzyme complex in a sample and comparing to control where decreased activity indicates reduced nutrition |
| 09/24/2002 | US6455088 Peptide/lipid complex formation by co-lyophilization |
| 09/24/2002 | US6455050 Human administration comprising a protective, highly-immunogenic, non-immunopotentiating copurified mixture of hn and f glycoproteins of human parainfluenza type 3 prepared by copurification from native piv-3 virus by affinity |
| 09/24/2002 | US6455049 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 09/24/2002 | US6455045 Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin |
| 09/24/2002 | US6455041 Immunogenic epitopes of the human zona pellucida protein (ZP1) |
| 09/24/2002 | US6455040 Sometimes referred to as ?tnfr-5? or ?tr5,? and now referred to hereinafter as ?trail receptor without intracellular domain? or ?trid.? |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | US6455025 Polysaccharide-peptide derivatives |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2063273C Surfactant compositions and methods |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/20/2002 | CA2715100A1 A novel receptor trem(triggering receptor expressed on myeloid cells) and uses thereof |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002073213A2 Assay |
| 09/19/2002 | WO2002073210A1 Method for promoting aggregate formation from protein subunits |
| 09/19/2002 | WO2002073202A1 Phycoerythrin labeled thyronine analogues and assays using the labeled analogues |
| 09/19/2002 | WO2002073193A1 Computer-based strategy for peptide and protein conformational ensemble enumeration and ligand affinity analysis |
| 09/19/2002 | WO2002073062A2 Synthetic molecular spring device |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072875A1 Method and compositions for evaluating risk of developing type 2 diabetes in people of chinese descent |
| 09/19/2002 | WO2002072874A1 METHOD OF SCREENING HNF4α AGONIST |
| 09/19/2002 | WO2002072865A2 Methods, kits and compositions of combination oligomers |
| 09/19/2002 | WO2002072861A1 Cd53 cell surface antigen |
| 09/19/2002 | WO2002072851A2 Lentiviral packaging constructs |
| 09/19/2002 | WO2002072847A2 Process for production of polypeptides |
| 09/19/2002 | WO2002072846A2 Synthetic genes and bacterial plasmids devoid of cpg |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072836A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | WO2002072833A1 Cloning of the cdna that codes for cup s 1, the major allergen of cupressus sempervirens |
| 09/19/2002 | WO2002072831A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072829A1 Novel g protein-coupled receptor protein and dna thereof |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072825A2 Human mrp5-like protein |
| 09/19/2002 | WO2002072824A2 Human transient receptor potential channel protein. |
| 09/19/2002 | WO2002072823A2 Human g protein-coupled receptor |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072819A1 Promoters |
| 09/19/2002 | WO2002072817A1 Novel protein, gene encoding the same and method of using the same |
| 09/19/2002 | WO2002072816A1 Novel mouse type kiss-1 receptor protein and dna thereof |
| 09/19/2002 | WO2002072814A2 Engineered baculoviruses and their use |
| 09/19/2002 | WO2002072803A2 Subgenomic replicons of the flavivirus dengue |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072798A1 Fas ligand-expressing hematopoietic cells for transplantation |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072793A2 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/19/2002 | WO2002072792A2 Heterologous fusion protein constructs comprising a leishmania antigen |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072787A2 Telomerase expression repressor proteins and methods of using the same |
| 09/19/2002 | WO2002072785A2 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 09/19/2002 | WO2002072782A2 Master activators of pathogen responsive genes |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072775A2 Lipid metabolism regulators in plants |
| 09/19/2002 | WO2002072774A2 Novel human transporter proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072771A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | WO2002072770A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072768A2 ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME |
| 09/19/2002 | WO2002072767A2 Mammalian neuralized family transcriptional regulators and uses therefor |
| 09/19/2002 | WO2002072766A2 Induction of tumor immunity by variants of folate binding protein |
| 09/19/2002 | WO2002072765A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/19/2002 | WO2002072764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | WO2002072763A2 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | WO2002072761A2 Polypeptides interactive with bcl-x¿l? |
| 09/19/2002 | WO2002072757A2 Novel proteins and nucleic acids encoding same |
| 09/19/2002 | WO2002072755A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072633A1 Novel overexpressed protein in prostate cancer |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072629A1 Immunopotentiators |
| 09/19/2002 | WO2002072628A1 Physiologically active polypeptide and polynucleotide encoding the same |
| 09/19/2002 | WO2002072627A2 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| 09/19/2002 | WO2002072625A1 The preparation and usage of plasmodium fusion antigen |
| 09/19/2002 | WO2002072624A2 Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| 09/19/2002 | WO2002072623A1 Genes and proteins, and their use |
| 09/19/2002 | WO2002072622A2 Vaccine antigens against infection by chlamydia trachomatis |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072614A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/19/2002 | WO2002072612A2 Peptidic modulators of the androgen receptor |
| 09/19/2002 | WO2002072611A2 Novel human egf-family proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072610A2 Rbp1l1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 09/19/2002 | WO2002072609A2 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072606A2 Epitope testing using hla |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072603A2 Novel human dectin proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072602A2 Somatostatin antagonists |
| 09/19/2002 | WO2002072601A2 Apoptosis modulator bcl-b and methods for making and using same |